These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 36051093)
1. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. Hao WW; Xu F World J Gastrointest Oncol; 2022 Jul; 14(7):1239-1251. PubMed ID: 36051093 [TBL] [Abstract][Full Text] [Related]
2. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer Liao H; Zhang L; Lu S; Li W; Dong W Front Genet; 2022; 13():848926. PubMed ID: 35812733 [No Abstract] [Full Text] [Related]
3. [SERPINE2 promotes cellular migration and invasion in esophageal squamous cell carcinoma by activating β-catenin]. Zhang JL; Luo AP; Huang FR; Gong TY; Liu ZH Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):638-645. PubMed ID: 34289555 [No Abstract] [Full Text] [Related]
4. EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway. Zhang R; Liu J; Zhang W; Hua L; Qian LT; Zhou SB Cancer Cell Int; 2020; 20():20. PubMed ID: 31956298 [TBL] [Abstract][Full Text] [Related]
5. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma. Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869 [TBL] [Abstract][Full Text] [Related]
7. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239 [TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034 [TBL] [Abstract][Full Text] [Related]
10. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315 [TBL] [Abstract][Full Text] [Related]
11. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin. Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532 [TBL] [Abstract][Full Text] [Related]
12. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway. Duan X; Chen Y; Zhang K; Chen W; Zhao J; Dai X; Cao W; Dong Z; Mo S; Lu J Cell Signal; 2023 Sep; 109():110736. PubMed ID: 37263462 [TBL] [Abstract][Full Text] [Related]
13. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032 [TBL] [Abstract][Full Text] [Related]
15. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma. Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390 [TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway. Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155 [TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278 [TBL] [Abstract][Full Text] [Related]
18. NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway. Guo D; Yao W; Du X; Dong J; Zhang X; Shen W; Zhu S Discov Oncol; 2023 May; 14(1):80. PubMed ID: 37233832 [TBL] [Abstract][Full Text] [Related]
19. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway. Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]